Obstructive sleep apnea in combination with bronchial asthma and chronic obstructive pulmonary disease

Obstructive sleep apnea is a condition characterized by snoring, periodic collapse of the upper respiratory tract at the level of the pharynx and cessation of pulmonary ventilation with continued respiratory efforts, decreased blood oxygen levels, gross fragmentation of sleep and excessive daytime sleepiness. Bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) remain a global problem for humanity due to persistent high levels of morbidity and mortality from these diseases. OSA is a common comorbid condition in many diseases, including chronic bronchopulmonary diseases such as BA, COPD and others, and always affects the course of these diseases. The presence of OSA in such patients is associated with disease progression, lack of disease control, frequent exacerbations, and an unfavorable outcome. This category of patients is difficult to treat with standard treatment and achieve disease control. This should be the key aspect in considering the appropriateness of diagnostics for obstructive sleep apnea syndrome. Despite the available data on the combination of OSA with chronic lung diseases, practitioners in most cases do not recognize this disease, and patients are left without full treatment. Timely detection and correction of OSA can reduce the frequency of hospitalizations, improve the course of BA and COPD, and reduce mortality. It is still relevant to conduct large population studies to identify the comorbidity of OSA in COPD and asthma, which will allow the development of algorithms for the early diagnosis of OSA with appropriate correction.

1. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983;52(5):490–494. https://doi.org/10.1016/0002-9149(83)90013-9.

2. Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263–276. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC2699173/.

3. Bikov A, Losonczy G, Kunos L. Role of lung volume and airway inflammation in obstructive sleep apnea. Respir Investig. 2017;55(6):326–333. https://doi.org/10.1016/j.resinv.2017.08.009.

4. Wang Y, Hu K, Liu K, Li Z, Yang J, Dong Y et al. Obstructive sleep apnea exacerbates airway inflammation in patients with chronic obstructive pulmonary disease. Sleep Med. 2015;16(9):1123–1130. https://doi.org/10.1016/j.sleep.2015.04.019.

5. Shukla SD, Walters EH, Simpson JL, Keely S, Wark PA, O’Toole R, Hansbro PM. Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease. Respirology. 2020;25(1):53–63. https://doi.org/10.1111/resp.13722.

6. Bin Kim J, Seo BS, Kim JH. Effect of arousal on sympathetic overactivity in patients with obstructive sleep apnea. Sleep Med. 2019;62:86–91. https://doi.org/10.1016/j.sleep.2019.01.044.

7. Adir Y, Humbert M, Chaouat A. Sleep-related breathing disorders and pulmonary hypertension. Eur Respir J. 2021;57(1):2002258. https://doi.org/10.1183/13993003.02258-2020.

8. Zeidler MR, Martin JL, Kleerup EC, Schneider H, Mitchell MN, Hansel NN et al. Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS). Sleep. 2018;41(5):zsy044. https://doi.org/10.1093/sleep/zsy044.

9. Troy LK, Corte TJ. Sleep disordered breathing in interstitial lung disease: A review. World J Clin Cases. 2014;2(12):828–834. https://doi.org/10.12998/wjcc.v2.i12.828.

10. Wang Y, Liu K, Hu K, Yang J, Li Z, Nie M et al. Impact of obstructive sleep apnea on severe asthma exacerbations. Sleep Med. 2016;26:1–5. https://doi.org/10.1016/j.sleep.2016.06.013.

11. Kong DL, Qin Z, Shen H, Jin HY, Wang W, Wang ZF. Association of Obstructive Sleep Apnea with Asthma: A Meta-Analysis. Sci Rep. 2017;7(1):4088. https://doi.org/10.1038/s41598-017-04446-6.

12. Julien JY, Martin JG, Ernst P, Olivenstein R, Hamid Q, Lemière C et al. Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol. 2009;124(2):371–376. https://doi.org/10.1016/j.jaci.2009.05.016.

13. Teodorescu M, Barnet JH, Hagen EW, Palta M, Young TB, Peppard PE. Association between asthma and risk of developing obstructive sleep apnea. JAMA. 2015;313(2):156–164. https://doi.org/10.1001/jama.2014.17822.

14. Taillé C, Rouvel-Tallec A, Stoica M, Danel C, Dehoux M, Marin-Esteban V et al. Obstructive Sleep Apnoea Modulates Airway Inflammation and Remodelling in Severe Asthma. PLoS ONE. 2016;11(3):e0150042. https://doi.org/10.1371/journal.pone.0150042.

15. Becerra MB, Becerra BJ, Teodorescu M. Healthcare burden of obstructive sleep apnea and obesity among asthma hospitalizations: Results from the U.S.-based Nationwide Inpatient Sample. Respir Med. 2016;117:230–236. https://doi.org/10.1016/j.rmed.2016.06.020.

16. Prasad B, Nyenhuis SM, Weaver TE. Obstructive sleep apnea and asthma: Associations and treatment implications. Sleep Med Rev. 2014;18(2):165–171. https://doi.org/10.1016/j.smrv.2013.04.004.

17. Kim MY, Jo EJ, Kang SY, Chang YS, Yoon IY, Cho SH et al. Obstructive sleep apnea is associated with reduced quality of life in adult patients with asthma. Ann Allergy Asthma Immunol. 2013;110(4):253–257.e1. https://doi.org/10.1016/j.anai.2013.01.005.

18. Davies SE, Bishopp A, Wharton S, Turner AM, Mansur AH. Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with coexisting conditions? – A systematic review. Respir Med. 2018;143:18–30. https://doi.org/10.1016/j.rmed.2018.08.004.

19. Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis. 1988;137(6):1502–1504. https://doi.org/10.1164/ajrccm/137.6.1502.

20. Sheludko EG, Naumov DE, Perelman YuM, Kolosov VP. The problem of obstructive sleep apnea syndrome in asthmatic patients. Terapevticheskii Arkhiv. 2017;89(1):107–111. (In Russ.) https://doi.org/10.17116/terarkh2017891107-111.

21. Flenley DC. Sleep in chronic obstructive lung disease. Clin Chest Med. 1985;6(4):651–661. https://doi.org/10.1016/S0272-5231(21)00402-0.

22. Adler D, Bailly S, Benmerad M, Joyeux-Faure M, Jullian-Desayes I, Soccal PM et al. Clinical presentation and comorbidities of obstructive sleep apnea-COPD overlap syndrome. PLoS ONE. 2020;15(7):e0235331. https://doi.org/10.1371/journal.pone.0235331.

23. McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med. 2009;180(8):692–700. https://doi.org/10.1164/rccm.200903-0347PP.

24. Soler X, Gaio E, Powell FL, Ramsdell JW, Loredo JS, Malhotra A, Ries AL. High Prevalence of Obstructive Sleep Apnea in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2015;12(8):1219–1225. https://doi.org/10.1513/AnnalsATS.201407-336OC.

25. Taranto-Montemurro L, Messineo L, Perger E, Salameh M, Pini L, Corda L et al. Cardiac Sympathetic Hyperactivity in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea. COPD. 2016;13(6):706–711. https://doi.org/10.1080/15412555.2016.1199668.

26. Orr JE, Schmickl CN, Edwards BA, DeYoung PN, Brena R, Sun XS et al. Pathogenesis of obstructive sleep apnea in individuals with the COPD + OSA Overlap syndrome versus OSA alone. Physiol Rep. 2020;8(3):e14371. https://doi.org/10.14814/phy2.14371.

27. Malhotra A, Schwartz AR, Schneider H, Owens RL, Deyoung P, Han MK et al. Research Priorities in Pathophysiology for Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018;197(3):289–299. https://doi.org/10.1164/rccm.201712-2510ST.

28. Krachman SL, Tiwari R, Vega ME, Yu D, Soler X, Jaffe F et al. Effect of Emphysema Severity on the Apnea–Hypopnea Index in Smokers with Obstructive Sleep Apnea. Ann Am Thorac Soc. 2016;13(7):1129–1135. https://doi.org/10.1513/AnnalsATS.201511-765OC.

29. Kwon JS, Wolfe LF, Lu BS, Kalhan R. Hyperinflation is associated with lower sleep efficiency in COPD with co-existent obstructive sleep apnea. COPD. 2009;6(6):441–445. https://doi.org/10.3109/15412550903433000.

30. Soler X, Liao SY, Marin JM, Lorenzi-Filho G, Jen R, DeYoung P et al. Age, gender, neck circumference, and Epworth sleepiness scale do not predict obstructive sleep apnea (OSA) in moderate to severe chronic obstructive pulmonary disease (COPD): The challenge to predict OSA in advanced COPD. PLoS ONE. 2017;12(5):e0177289. https://doi.org/10.1371/journal.pone.0177289.

31. Adler D, Lozeron ED, Janssens JP, Soccal PM, Lador F, Brochard L, Pépin JL. Obstructive sleep apnea in patients surviving acute hypercapnic respiratory failure is best predicted by static hyperinflation. PLoS ONE. 2018;13(10):e0205669. https://doi.org/10.1371/journal.pone.0205669.

32. Mermigkis C, Kopanakis A, Foldvary-Schaefer N, Golish J, Polychronopoulos V, Schiza S et al. Health-related quality of life in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease (overlap syndrome). Int J Clin Pract. 2007;61(2):207–211. https://doi.org/10.1111/j.1742-1241.2006.01213.x.

33. Kendzerska T, Leung RS, Aaron SD, Ayas N, Sandoz JS, Gershon AS. Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome). Ann Am Thorac Soc. 2019;16(1):71–81. https://doi.org/10.1513/AnnalsATS.201802-136OC.

34. Ganga HV, Nair SU, Puppala VK, Miller WL. Risk of new-onset atrial fibrillation in elderly patients with the overlap syndrome: A retrospective cohort study. J Geriatr Cardiol. 2013;10(2):129–134. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC3708051/.

35. Putcha N, Crainiceanu C, Norato G, Samet J, Quan SF, Gottlieb DJ et al. Influence of Lung Function and Sleep-disordered Breathing on All-Cause Mortality. A Community-based Study. Am J Respir Crit Care Med. 2016;194(8):1007–1014. https://doi.org/10.1164/rccm.201511-2178OC.

36. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005;112(17):2660–2667. https://doi.org/10.1161/CIRCULATIONAHA.105.556746.

37. Vernooy JH, Küçükaycan M, Jacobs JA, Chavannes N, Buurman WA, Dentener MA, Wouters EF. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med. 2002;166(9):1218–1224. https://doi.org/10.1164/rccm.2202023.

38. Adler D, Dupuis-Lozeron E, Merlet-Violet R, Pépin JL, Espa-Cervena K, Muller H et al. Comorbidities and Subgroups of Patients Surviving Severe Acute Hypercapnic Respiratory Failure in the Intensive Care Unit. Am J Respir Crit Care Med. 2017;196(2):200–207. https://doi.org/10.1164/rccm.201608-1666OC.

39. Valko L, Baglyas S, Gyarmathy VA, Gal J, Lorx A. Home mechanical ventilation: Quality of life patterns after six months of treatment. BMC Pulm Med. 2020;20(1):221. https://doi.org/10.1186/s12890-020-01262-z.

40. Naranjo M, Willes L, Prillaman BA, Quan SF, Sharma S. Undiagnosed OSA May Significantly Affect Outcomes in Adults Admitted for COPD in an Inner-City Hospital. Chest. 2020;158(3):1198–1207. https://doi.org/10.1016/j.chest.2020.03.036.

41. Sharma B, Neilan TG, Kwong RY, Mandry D, Owens RL, McSharry D et al. Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea. COPD. 2013;10(1):4–10. https://doi.org/10.3109/15412555.2012.719050.

42. Du W, Liu J, Zhou J, Ye D, OuYang Y, Deng Q. Obstructive sleep apnea, COPD, the overlap syndrome, and mortality: results from the 2005–2008 National Health and Nutrition Examination Survey. Int J Chronic Obstr Pulmon Dis. 2018;13:665–674. https://doi.org/10.2147/COPD.S148735.

43. Shawon SR, Perret JL, Senaratna CV, Lodge C, Hamilton GS, Dharmage SC. Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: A systematic review. Sleep Med Rev. 2016;32:58–68. https://doi.org/10.1016/j.smrv.2016.02.007.

44. Hajian B, De Backer J, Sneyers C, Ferreira F, Barboza KC, Leemans G et al. Pathophysiological mechanism of long-term noninvasive ventilation in stable hypercapnic patients with COPD using functional respiratory imaging. Int J Chron Obstruct Pulmon Dis. 2017;12:2197–2205. https://doi.org/10.2147/COPD.S136412.

45. Toraldo DM, De Nuccio F, Nicolardi G. Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): A 24-month follow-up study. Sleep Breath. 2010;14(2):115–123. https://doi.org/10.1007/s11325-009-0291-1.

46. Stanchina ML, Welicky LM, Donat W, Lee D, Corrao W, Malhotra A. Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome. J Clin Sleep Med. 2013;9(8):767–772. https://doi.org/10.5664/jcsm.2916.